You are viewing the site in preview mode

Skip to main content

Advertisement

Figure 2 | BMC Infectious Diseases

Figure 2

From: Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response

Figure 2

Percentage of PEx achieving a 1 or 2-log reduction inP. aeruginosasputum density at end of antibacterial therapy as a function of the number of empirically provided antibiotics within vitropredicted activity from admission sputum sample. A). Antibiotics with activity against Mucoid isolates. B). Antibiotics with activity against Non-Mucoid isolates.

Back to article page